GB0518027D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0518027D0 GB0518027D0 GB0518027A GB0518027A GB0518027D0 GB 0518027 D0 GB0518027 D0 GB 0518027D0 GB 0518027 A GB0518027 A GB 0518027A GB 0518027 A GB0518027 A GB 0518027A GB 0518027 D0 GB0518027 D0 GB 0518027D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0518027A GB0518027D0 (en) | 2005-09-05 | 2005-09-05 | Compounds |
CA002621272A CA2621272A1 (en) | 2005-09-05 | 2006-09-05 | Anchoring disruption molecules |
PCT/GB2006/003273 WO2007028969A2 (en) | 2005-09-05 | 2006-09-05 | Anchoring disruption molecules |
EP06779293A EP1928896A2 (en) | 2005-09-05 | 2006-09-05 | Anchoring disruption molecules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0518027A GB0518027D0 (en) | 2005-09-05 | 2005-09-05 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0518027D0 true GB0518027D0 (en) | 2005-10-12 |
Family
ID=35220864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0518027A Ceased GB0518027D0 (en) | 2005-09-05 | 2005-09-05 | Compounds |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1928896A2 (en) |
CA (1) | CA2621272A1 (en) |
GB (1) | GB0518027D0 (en) |
WO (1) | WO2007028969A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2142571A4 (en) | 2007-05-02 | 2010-05-05 | Intrexon Corp | Pp1 ligands |
EP2225002A4 (en) | 2007-12-31 | 2011-06-22 | Nanocor Therapeutics Inc | Rna interference for the treatment of heart failure |
GB201208775D0 (en) | 2012-05-18 | 2012-07-04 | Uni I Oslo | Chemical compounds |
GB201320506D0 (en) | 2013-11-26 | 2014-01-01 | Uni I Oslo | Cyclic amino compounds for the use in the treatment of cardiac disorders |
CN114632147A (en) * | 2021-11-09 | 2022-06-17 | 南京大学 | Treatment of cardiomyopathy in human subjects |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO971997D0 (en) * | 1997-04-29 | 1997-04-29 | Kjetil Tasken | Use of immunomodulatory agents |
US6011013A (en) * | 1997-06-20 | 2000-01-04 | Oregon Health Sciences University | Contraceptive compositions and methods |
US6538022B1 (en) * | 1997-09-24 | 2003-03-25 | Orion Corporation | Compounds for deactivating phospholamban function on Ca-ATPase (phopholamban inhibitors) |
CN1354671A (en) * | 1998-11-02 | 2002-06-19 | 加利福尼亚大学董事会 | Method for inhibition of phospholamban activity for treatment of cardiac disease and heart failure |
WO2005035003A2 (en) * | 2003-09-22 | 2005-04-21 | Dihedron Corporation | Compositions and methods for increasing drug efficiency |
GB0421356D0 (en) * | 2004-09-24 | 2004-10-27 | Univ Oslo | Inhibitors |
GB0421355D0 (en) * | 2004-09-24 | 2004-10-27 | Univ Oslo | Inhibitors |
-
2005
- 2005-09-05 GB GB0518027A patent/GB0518027D0/en not_active Ceased
-
2006
- 2006-09-05 CA CA002621272A patent/CA2621272A1/en not_active Abandoned
- 2006-09-05 WO PCT/GB2006/003273 patent/WO2007028969A2/en active Application Filing
- 2006-09-05 EP EP06779293A patent/EP1928896A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1928896A2 (en) | 2008-06-11 |
WO2007028969A3 (en) | 2007-08-09 |
WO2007028969A2 (en) | 2007-03-15 |
CA2621272A1 (en) | 2007-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0508472D0 (en) | Compounds | |
GB0503962D0 (en) | Compounds | |
GB0507602D0 (en) | Compounds | |
GB0502418D0 (en) | Compounds | |
EP1961741A4 (en) | m-CARBAZOLYLPHENYL COMPOUNDS | |
GB0508463D0 (en) | Compounds | |
GB0502310D0 (en) | Compounds | |
GB0502299D0 (en) | Compounds | |
AP2007004220A0 (en) | Motilide compounds | |
GB0505084D0 (en) | Compounds | |
GB0503961D0 (en) | Compounds | |
EP1907385A4 (en) | Compounds | |
GB0506467D0 (en) | Compounds | |
GB0505086D0 (en) | Compounds | |
GB0518027D0 (en) | Compounds | |
GB0508460D0 (en) | Compounds | |
GB0505509D0 (en) | Compounds | |
GB0505735D0 (en) | Compounds | |
GB0501985D0 (en) | Compounds | |
EP1867650A4 (en) | Hydroxymethylboron compounds | |
GB0505085D0 (en) | Compounds | |
GB0501984D0 (en) | Compounds | |
GB0503145D0 (en) | Compounds | |
GB0507387D0 (en) | Compounds | |
GB0505214D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |